Avibactam restored the in-vitro antibacterial activity of ceftazidime, ceftaroline, and aztreonam against isogenic Escherichia coli expressing class A, class C, and class D β-lactamases. The enzymes included TEM and CTX-M extended spectrum β-lactamases, ACT, CMY and FOX AmpC-type enzymes, and carbapenemases including rarer KPC variants and OXA-139
of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV b-lacta...
Abstract Background In recent years, the incidence of carbapenem-resistant Enterobacteriaceae (CRE) ...
Guoping Lu,1,2 Hao Tang,3 Zhaoxin Xia,1 Wensu Yang,1 Huaming Xu,1 Zhen Liu,1 Shenwang Ni,1 Zhaofei W...
The novel -lactamase inhibitor avibactam is a potent inhibitor of class A, class C, and some class D...
The -lactamase inhibitor avibactam (NXL104) displays potent inhibition of both class A and C enzymes...
To evaluate the in vitro effects of the combination of ceftazidime and avibactam on the MICs of both...
To evaluate the in vitro effects of the combination of ceftazidime and avibactam on the MICs of both...
The objective of this study was to investigate the in vitro antibacterial activity of avibactam (for...
Ceftazidime-avibactam (MIC50/90, 0.12/0.25g/ml) inhibited 99.9 % (20,698/20,709) of Enterobacteriace...
The activity of ceftazidime-avibactam was compared with that of ceftazidime alone and meropenem agai...
The activities of the novel-lactam–-lactamase inhibitor combination ceftazidime-avibactam and compar...
Avibactam (formerly NXL104, AVE1330A) is a synthetic non-β-lactam, β-lactamase inhibitor that inhibi...
Based upon knowledge of the hydrolytic profile of major β-lactamases found in Gram negative bacteria...
Based upon knowledge of the hydrolytic profile of major β-lactamases found in Gram-negative bacteria...
β-Lactamases are the most important mechanisms of resistance to the β-lactam antibacterials. There a...
of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV b-lacta...
Abstract Background In recent years, the incidence of carbapenem-resistant Enterobacteriaceae (CRE) ...
Guoping Lu,1,2 Hao Tang,3 Zhaoxin Xia,1 Wensu Yang,1 Huaming Xu,1 Zhen Liu,1 Shenwang Ni,1 Zhaofei W...
The novel -lactamase inhibitor avibactam is a potent inhibitor of class A, class C, and some class D...
The -lactamase inhibitor avibactam (NXL104) displays potent inhibition of both class A and C enzymes...
To evaluate the in vitro effects of the combination of ceftazidime and avibactam on the MICs of both...
To evaluate the in vitro effects of the combination of ceftazidime and avibactam on the MICs of both...
The objective of this study was to investigate the in vitro antibacterial activity of avibactam (for...
Ceftazidime-avibactam (MIC50/90, 0.12/0.25g/ml) inhibited 99.9 % (20,698/20,709) of Enterobacteriace...
The activity of ceftazidime-avibactam was compared with that of ceftazidime alone and meropenem agai...
The activities of the novel-lactam–-lactamase inhibitor combination ceftazidime-avibactam and compar...
Avibactam (formerly NXL104, AVE1330A) is a synthetic non-β-lactam, β-lactamase inhibitor that inhibi...
Based upon knowledge of the hydrolytic profile of major β-lactamases found in Gram negative bacteria...
Based upon knowledge of the hydrolytic profile of major β-lactamases found in Gram-negative bacteria...
β-Lactamases are the most important mechanisms of resistance to the β-lactam antibacterials. There a...
of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV b-lacta...
Abstract Background In recent years, the incidence of carbapenem-resistant Enterobacteriaceae (CRE) ...
Guoping Lu,1,2 Hao Tang,3 Zhaoxin Xia,1 Wensu Yang,1 Huaming Xu,1 Zhen Liu,1 Shenwang Ni,1 Zhaofei W...